October 2, 2012 at 11:27 PM
MORRISTOWN, NJ- As the leading cause of death in the world, cancer does not discriminate. It claims lives of young, old, black and white. However, Tuesday morning, October 2nd, the American Cancer Society presented a groundbreaking study at the Morristown Medical Center that may help prevent the disease in the foreseeable future.
The Atlantic Health System, Realogy Corporation and The Greater Morristown and Madison Area YMCAs all partnered with the American Cancer Society and are looking for participants in the northwestern New Jersey area for the study.
In attendance at the event were Brian Slomovitz, Medical Director of Oncology Research at Atlantic Health, David Weaving, Executive Vice President at Realogy Corporation, Sue Bowens, Director of Marketing at the Greater Morristown YMCA, Robert Conley, Mayor of Madison and Vice President of Operations at the Madison Area YMCA, Congressmen Rodney Frelinghuysen and Leonard Lance and cancer survivors Francine Saliter and Jane Rubin.
“We need your help. It is so important for the community,” said Robin Albers, Regional Vice President of the American Cancer Society.
The study is called the Cancer Prevention Study-3 (CPS-3) and its goal is to better understand the lifestyle, environmental and genetic factors that cause or prevent cancer. While similar studies have been taking place for decades, researchers hope this one finds more information that can really benefit people and save lives. The American Cancer Society’s Department of Epidemiology & Surveillance Research is recruiting 300,000 adults across the U.S. and Puerto Rico for this study.
Men and women who are between the ages of 30 and 65 and have never been diagnosed with cancer are eligible to sign up. To enroll, individuals provide a waist measurement, give a small blood sample and complete a baseline and enrollment survey. Over the course of the study, participants will be asked to fill out follow-up surveys every few years for the next 20-30 years. To sign up go to www.wpc3northwestnj.org or call toll free1- (888)-604-5888.
Saliter was elated about the new study. She pledged her full support to the research and believes it has the potential to save many lives.
“No one should ever have to give a diagnosis of cancer or to live in fear of a diagnosis,” she said. “This is a call to action for all of us to stand up and be a champion against this disease.”
Congressman Leonard Lance, who serves on the Health Subcommittee, said he was extremely proud to see the new study created. Lance, who sponsored the Recalcitrant Cancer Act, which was recently approved by Congress, supports CPS-3 and hopes it can help stop the deadly disease.
“With our highly diverse population here in New Jersey this is an excellent place to conduct the study,” Lance said. “I hope that this grassroots effort yields answers to the many questions that we have about the nature of cancer.”